[Sepsis therapy -- how effective are the therapy strategies?].
Brunkhorst
F  M
F
Reinhart
K
K
D000890:Anti-Infective Agents / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D015337:Multicenter Studies as Topic; D011110:Polymorphism, Genetic; D011486:Protein C / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy* / Q000235:genetics
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins